MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
13.51
+1.95 (16.87%)
At close: Apr 14, 2026, 4:00 PM EDT
13.03
-0.48 (-3.55%)
Pre-market: Apr 15, 2026, 7:17 AM EDT

MiNK Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for MiNK Therapeutics stock has a target of 35, which predicts a 159.07% increase from the current stock price of 13.51.

Price Target: $35 (+159.07%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$35$35$35$35
Change+159.07%+159.07%+159.07%+159.07%

Analyst Ratings

The average analyst rating for MiNK Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy111111
Buy111110
Hold111111
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong BuyReiterates$35+159.07%Apr 1, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$35
Strong BuyUpgrades$35+159.07%Aug 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$35
HoldDowngrades$35+159.07%Jul 15, 2025
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong BuyReiterates$35+159.07%Mar 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.33
from -2.93
EPS Next Year
-3.52
from -3.33
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-11.61-8.31-6.54-2.86-2.93-3.33-3.52
EPS Growth
-------
Forward PE
-------
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-3.18-3.49
Avg-3.33-3.52
Low-3.43-3.51

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.